The Canadian Cancer Trials Group (CCTG) is a cooperative oncology group that designs and administers clinical trials in cancer therapy, supportive care and prevention across Canada. We support a collaborative network of researchers, physicians, scientists and statisticians internationally recognized for finding the treatments that give people with cancer longer, better quality lives.
Created in 1980, the group has run trials resulting in major, life-saving breakthroughs in breast, colorectal, blood, lung, ovarian, brain and prostate cancer. The network is made of more than 80 member institution, comprising over 2100 Canadian investigators who have facilitated over 500 trials in more than 40 countries.
CCTG’s Central Operations and Statistics Office is located in the Cancer Research Institute at Queen’s University, with in-house faculty researchers that include clinician scientists, researchers in community health and epidemiology, and biostatisticians.
Our group is proud to be one of the national programmes of the Canadian Cancer Society Research Institute (CCSRI), and supported by the Canadian Cancer Society (CCS).
CCTG is the only non-American partner of the US National Clinical Trials Network and internationally they have collaborated with sites and other cooperative groups around the world. These international partnerships are central to the success of their cancer clinical trials and crucial to the advancement of the cancer research agenda.
To develop and conduct clinical trials aimed at improving the treatment and prevention of cancer with the ultimate goal of reducing morbidity and mortality from this disease.
More information: CCTG at Queen's plays a central role in the progress of cancer care